Check Cap Ltd
check-cap.comWhat Do They Do?
Designs, integrates and manages artificial-intelligence software and robotic systems for hotels, casinos, convention centers and other high-traffic facilities.
20-F for FY2025, filed Apr 27, 2026
Who Are Their Customers?
Provides turnkey deployments to large hospitality groups and other enterprises, handling equipment sourcing, rollout, financing and ongoing operations.
20-F for FY2025, filed Apr 27, 2026MBody AI provides turnkey solutions to enterprise customers, including hardware procurement, deployment, financing, and ongoing operational…View ↗
How Are They Changing?
From screening to automation
The older report centers on C-Scan, a capsule-based screening test; the latest report says C-Scan development has stopped and expects MBody AI's robotic and software systems to become the combined company's principal business after the merger.
20-F for FY2022, filed Mar 31, 2023 20-F for FY2025, filed Apr 27, 2026We are a clinical stage medical diagnostics company aiming to redefine CRC screening through the introduction of C-Scan®, the first and…View ↗
On June 6, 2023, we announced that after further review of additional data and interaction with the FDA on a revised pivotal study protocol…View ↗
On September 12, 2025, we entered into the Merger Agreement, pursuant to which MBody AI will become a wholly-owned subsidiary of the…View ↗
MBody AI” is a Nevada corporation incorporated on October 7, 2024 and headquartered in Las Vegas, Nevada. MBody AI is an artificial…View ↗
Who Do They Compete With?
Competes with Olympus, Pentax, Hoya, Fuji Film, General Electric Healthcare Systems, Siemens Medical Solutions, Philips Healthcare, Toshiba, Medtronic, Exact Sciences, Polymedco, Epigenomics, EDP Biotech, Illumina, Quest Diagnostics, Freenome, Grail, Guardant, Genoscopy, and Universal DX
20-F for FY2025, filed Apr 27, 2026Competition for C-Scan comes from traditional well-entrenched manufacturers of tests and equipment for CRC screening, such as colonoscopy…View ↗
Loading...
